Acro Biomedical (ACBM) Profit After Tax (2015 - 2026)
Acro Biomedical (ACBM) posted Profit After Tax of -$21356.0 for Q2 2026, down 150.22% on a QoQ basis from $42526.0 in Q4 2025, and down 37.23% year-over-year from -$34023.6 in Q2 2025.
Powered by 
Analysis
Acro Biomedical (ACBM) Profit After Tax (2015 - 2026) Analysis & Trends
Acro Biomedical has reported Profit After Tax for 12 years, with the latest figure at -$21356.0 in Q2 2026.
- On a quarterly basis, Profit After Tax fell 37.23% year-over-year to -$21356.0 in Q2 2026; TTM through Jun 2026 was -$112201.0, a 139.93% decrease from a year earlier, with the FY2025 full-year figure at -$101146.0, down 139.13% from the prior year.
- Profit After Tax was -$21356.0 for Q2 2026 at Acro Biomedical, down from $42526.0 in the prior quarter.
- The five-year high for Profit After Tax was $42526.0 in Q4 2025, with the low at -$4.0 million in Q3 2022.
- Average Profit After Tax over 5 years is -$1.5 million, with a median of -$21356.0 recorded in 2026.
- The sharpest annual moves came in 2022 and 2025: Profit After Tax slumped 6503.69% in 2022, then jumped 498.44% in 2025.
- Over 5 years, Profit After Tax stood at -$3.9 million in 2022, then soared by 99.54% to -$18240.0 in 2023, then surged by 41.49% to -$10673.0 in 2024, then surged by 498.44% to $42526.0 in 2025, then tumbled by 150.22% to -$21356.0 in 2026.
- The last three Profit After Tax figures came in at -$21356.0 (Q2 2026), $42526.0 (Q4 2025), and -$117809.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.27 Bn | 68.90 Bn | 3.30 Bn | 719.00 Mn |
| 2 | Kenvue | 34.17 Bn | 33.06 Bn | 2.30 Bn | 456.00 Mn |
| 3 | Kimberly Clark | 32.86 Bn | 31.91 Bn | 1.60 Bn | 410.00 Mn |
| 4 | Bath & Body Works | 3.85 Bn | 3.05 Bn | 692.00 Mn | 118.00 Mn |
| 5 | Prestige Consumer Healthcare | 2.32 Bn | 2.26 Bn | - | - |
| 6 | Perrigo | 1.99 Bn | 1.59 Bn | 313.90 Mn | 88.50 Mn |
| 7 | Herbalife | 1.32 Bn | 946.20 Mn | 1.03 Bn | -26.50 Mn |
| 8 | Edgewell Personal Care | 1.24 Bn | 842.99 Mn | 242.50 Mn | 13.70 Mn |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | - |
| 10 | Acro Biomedical | 1.80 Mn | 1.80 Mn | - | -21,356.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -21,356.00 |
| Dec 31, 2025 | 42,526.00 |
| Sep 30, 2025 | -117,809.00 |
| Jun 30, 2025 | -15,562.00 |
| Mar 31, 2025 | -10,301.00 |
| Dec 31, 2024 | -10,673.00 |
| Sep 30, 2024 | -10,229.00 |
| Jun 30, 2024 | -10,143.00 |
| Mar 31, 2024 | -11,252.00 |
| Dec 31, 2023 | -18,240.00 |
| Sep 30, 2023 | -1.59 Mn |
| Jun 30, 2023 | -3.20 Mn |
| Mar 31, 2023 | -4.00 Mn |
| Dec 31, 2022 | -3.93 Mn |
| Sep 30, 2022 | -4.01 Mn |
| Jun 30, 2022 | -4.00 Mn |
| Mar 31, 2022 | -3.93 Mn |
| Dec 31, 2021 | -3.85 Mn |
| Sep 30, 2021 | -2.99 Mn |
| Jun 30, 2021 | -794,687.00 |